LifeMD, Inc. (LFMD)
Total Valuation
LifeMD has a market cap or net worth of $401.83 million. The enterprise value is $387.62 million.
Market Cap | 401.83M |
Enterprise Value | 387.62M |
Important Dates
The last earnings date was Monday, March 11, 2024, after market close.
Earnings Date | Mar 11, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
LifeMD has 40.37 million shares outstanding. The number of shares has increased by 9.45% in one year.
Shares Outstanding | 40.37M |
Shares Change (YoY) | +9.45% |
Shares Change (QoQ) | +6.58% |
Owned by Insiders (%) | 19.81% |
Owned by Institutions (%) | 31.09% |
Float | 30.97M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.63 |
Forward PS | 2.06 |
PB Ratio | 114.63 |
P/FCF Ratio | 1,704.00 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.54 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 1,643.72 |
Financial Position
The company has a current ratio of 1.23, with a Debt / Equity ratio of 5.40.
Current Ratio | 1.23 |
Quick Ratio | 1.10 |
Debt / Equity | 5.40 |
Debt / EBITDA | n/a |
Debt / FCF | 80.28 |
Interest Coverage | -6.77 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -56.30% |
Return on Capital (ROIC) | -64.58% |
Revenue Per Employee | $736,942 |
Profits Per Employee | -$114,504 |
Employee Count | 207 |
Asset Turnover | 3.62 |
Inventory Turnover | 5.85 |
Taxes
In the past 12 months, LifeMD has paid $428,000 in taxes.
Income Tax | 428,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +567.53% in the last 52 weeks. The beta is 1.42, so LifeMD's price volatility has been higher than the market average.
Beta (1Y) | 1.42 |
52-Week Price Change | +567.53% |
50-Day Moving Average | 7.65 |
200-Day Moving Average | 6.12 |
Relative Strength Index (RSI) | 61.01 |
Average Volume (30 Days) | 911,965 |
Short Selling Information
The latest short interest is 1.93 million, so 4.78% of the outstanding shares have been sold short.
Short Interest | 1.93M |
Short Previous Month | 2.73M |
Short % of Shares Out | 4.78% |
Short % of Float | 6.24% |
Short Ratio (days to cover) | 2.58 |
Income Statement
In the last 12 months, LifeMD had revenue of $152.55 million and -$23.70 million in losses. Loss per share was -$0.70.
Revenue | 152.55M |
Gross Profit | 133.65M |
Operating Income | -14.49M |
Pretax Income | -20.17M |
Net Income | -23.70M |
EBITDA | -10.97M |
EBIT | -17.57M |
Loss Per Share | -$0.70 |
Balance Sheet
The company has $33.15 million in cash and $18.93 million in debt, giving a net cash position of $14.21 million or $0.35 per share.
Cash & Cash Equivalents | 33.15M |
Total Debt | 18.93M |
Net Cash | 14.21M |
Net Cash Per Share | $0.35 |
Equity / Book Value | 3.51M |
Book Value Per Share | 0.09 |
Working Capital | 7.82M |
Cash Flow
In the last 12 months, operating cash flow was $8.82 million and capital expenditures -$8.58 million, giving a free cash flow of $235,816.
Operating Cash Flow | 8.82M |
Capital Expenditures | -8.58M |
Free Cash Flow | 235,816 |
FCF Per Share | $0.01 |
Margins
Gross margin is 87.61%, with operating and profit margins of -9.50% and -15.54%.
Gross Margin | 87.61% |
Operating Margin | -9.50% |
Pretax Margin | -13.22% |
Profit Margin | -15.54% |
EBITDA Margin | -7.19% |
EBIT Margin | -11.52% |
FCF Margin | 0.15% |
Dividends & Yields
LifeMD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -9.45% |
Shareholder Yield | -9.45% |
Earnings Yield | -5.90% |
FCF Yield | 0.06% |
Analyst Forecast
The average price target for LifeMD is $12.60, which is 22.57% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $12.60 |
Price Target Difference | 22.57% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 14, 2020. It was a reverse split with a ratio of 1:5.
Last Split Date | Oct 14, 2020 |
Split Type | Reverse |
Split Ratio | 1:5 |
Scores
LifeMD has an Altman Z-Score of 1.2 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.2 |
Piotroski F-Score | 5 |